Start 30MG Injectable

Anti-Malaria

Start 30MG Injectable

Composition

Artesunate 30 mg Injectable

Presentation

Each pack contains: Powder for injection, in a 30 mg vial

With

  • One ampoule of 0.5ml Sodium Bicarbonate Injection 5% w/v - Water for Injection q.s,
  • One ampoule of 2.5 ml Sodium Chloride Injection 0.9% w/v - Water for Injection q.s.

Usage

Dissolve the powder in the entire 5% sodium bicarbonate and shake until a clear solution is obtained. Then add 0.9% sodium chloride to the vial

  • 5 ml of 0.9% sodium chloride to obtain 6 ml of 10 mg / ml artesunate solution, for IV injection
  • 2 ml of 0.9% sodium to obtain 3 ml of artesunate solution of 20 mg / ml, for IM injection

with a 1 ml ampoule of 5% sodium bicarbonate and a 5 ml ampoule of 0.9% sodium chloride, for slow IV injection (3 to 5 minutes) or slow IM. NU NCA MANAGE Perfusion IV .

Each vial contains:

  • Artesunate (Sterile) 30mg

Indications

Used for acute attack and cerebral type of malaria.

Posology

Injectable artesunate is administered intravenously (IV) or intramuscularly (IM) for the treatment of severe malaria caused by P. falciparum.

The WHO strongly recommends the use of IV or IM artesunate in adults and children suffering from severe malaria (including infants, pregnant women in all trimesters, and lactating women) for at least 24 hours and until the patient can tolerate a full course of oral ACT therapy.

Dosing table
Dosing table for IV artesunate treatment
Category Dose
Children <20kg 3 mg/kg bodyweight per dose
Children and adults >20kg 2.4 mg/kg bodyweight per dose

When using artesunate as an IM injection, give adults and children a single intramuscular dose of artesunate (as a pre-referral) and refer to an appropriate facility for further care.

Dosing Regimen

  • Day 1 Dose 1: on admission (0 Hours)
  • Day 1 Dose 2: 12 hours later
  • Day 2 Dose 3: 24 hours after first dose

Start All Products